**Core Concept**
Transcranial Magnetic Stimulation (TMS) is a non-invasive brain stimulation technique used to treat various neurological disorders, including Parkinson's disease. The primary goal of TMS in Parkinsonism is to modulate abnormal brain activity and improve motor symptoms.

**Why the Correct Answer is Right**
The most effective site for TMS in reducing Parkinsonism symptoms is the **Primary Motor Cortex (M1)**, specifically targeting the **dorsolateral prefrontal cortex**. This region is involved in motor planning and execution, and stimulation here can help alleviate symptoms such as tremors, rigidity, and bradykinesia. The M1 is chosen due to its proximity to the motor cortex and its ability to modulate corticospinal tract activity.

**Why Each Wrong Option is Incorrect**
* **Option A:** The **Primary Sensory Cortex (S1)** is not a primary target for TMS in Parkinsonism, as it is more involved in processing sensory information rather than motor planning.
* **Option B:** The **Basal Ganglia** is a deep brain structure involved in motor control, but TMS is not directly targeted at this region due to its depth and complexity.
* **Option D:** The **Cerebellum** plays a role in motor coordination and learning, but it is not the primary target for TMS in Parkinsonism.

**Clinical Pearl / High-Yield Fact**
When using TMS for Parkinsonism, it's essential to note that the optimal stimulation frequency is typically **1-2 Hz**, which is lower than the frequency used for other indications such as depression.

**Correct Answer:** C.